vs
Side-by-side financial comparison of Solowin Holdings, Ltd. (AXG) and Longeveron Inc. (LGVN). Click either name above to swap in a different company.
Solowin Holdings, Ltd. is the larger business by last-quarter revenue ($410.0K vs $365.0K, roughly 1.1× Longeveron Inc.).
Longeveron Inc. is a clinical-stage biotechnology company specializing in regenerative medicine therapies for aging-related and life-threatening conditions. Its lead candidate targets geriatric frailty, Alzheimer's disease, and cardiovascular disorders, with core operations focused on the U.S. biopharmaceutical market.
AXG vs LGVN — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $410.0K | $365.0K |
| Net Profit | — | $-5.4M |
| Gross Margin | — | 70.4% |
| Operating Margin | -34.1% | -1479.2% |
| Net Margin | — | -1491.5% |
| Revenue YoY | — | -39.5% |
| Net Profit YoY | — | -33.3% |
| EPS (diluted) | — | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $365.0K | ||
| Q3 25 | — | $137.0K | ||
| Q2 25 | — | $316.0K | ||
| Q1 25 | — | $381.0K | ||
| Q4 24 | — | $603.0K | ||
| Q3 24 | $410.0K | $773.0K | ||
| Q2 24 | — | $468.0K | ||
| Q1 24 | — | $548.0K |
| Q4 25 | — | $-5.4M | ||
| Q3 25 | — | $-7.2M | ||
| Q2 25 | — | $-5.0M | ||
| Q1 25 | — | $-5.0M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | — | $-4.4M | ||
| Q2 24 | — | $-3.4M | ||
| Q1 24 | — | $-4.1M |
| Q4 25 | — | 70.4% | ||
| Q3 25 | — | 91.2% | ||
| Q2 25 | — | 46.2% | ||
| Q1 25 | — | 72.2% | ||
| Q4 24 | — | 87.7% | ||
| Q3 24 | — | 88.2% | ||
| Q2 24 | — | 73.5% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | — | -1479.2% | ||
| Q3 25 | — | -5335.8% | ||
| Q2 25 | — | -1707.9% | ||
| Q1 25 | — | -1359.8% | ||
| Q4 24 | — | -710.3% | ||
| Q3 24 | -34.1% | -601.4% | ||
| Q2 24 | — | -747.9% | ||
| Q1 24 | — | -746.4% |
| Q4 25 | — | -1491.5% | ||
| Q3 25 | — | -5270.8% | ||
| Q2 25 | — | -1591.1% | ||
| Q1 25 | — | -1315.2% | ||
| Q4 24 | — | -677.1% | ||
| Q3 24 | — | -571.7% | ||
| Q2 24 | — | -729.3% | ||
| Q1 24 | — | -740.5% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | — | $-0.39 | ||
| Q2 25 | — | $-0.33 | ||
| Q1 25 | — | $-0.34 | ||
| Q4 24 | — | $1.16 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-1.83 | ||
| Q1 24 | — | $-1.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $4.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.0M | $5.7M |
| Total Assets | $13.1M | $10.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.7M | ||
| Q3 25 | — | $9.2M | ||
| Q2 25 | — | $10.3M | ||
| Q1 25 | — | $14.3M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $2.5M | $22.8M | ||
| Q2 24 | — | $12.4M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | $5.7M | ||
| Q3 25 | — | $10.0M | ||
| Q2 25 | — | $12.7M | ||
| Q1 25 | — | $17.2M | ||
| Q4 24 | — | $21.9M | ||
| Q3 24 | $6.0M | $25.6M | ||
| Q2 24 | — | $14.9M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | $10.3M | ||
| Q3 25 | — | $15.6M | ||
| Q2 25 | — | $16.7M | ||
| Q1 25 | — | $20.8M | ||
| Q4 24 | — | $25.6M | ||
| Q3 24 | $13.1M | $29.9M | ||
| Q2 24 | — | $19.4M | ||
| Q1 24 | — | $9.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $-5.3M |
| Free Cash FlowOCF − Capex | $-1.6M | — |
| FCF MarginFCF / Revenue | -392.9% | — |
| Capex IntensityCapex / Revenue | 4.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | $-4.7M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | $-1.6M | $-2.8M | ||
| Q2 24 | — | $-4.6M | ||
| Q1 24 | — | $-3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-5.1M | ||
| Q2 25 | — | $-3.8M | ||
| Q1 25 | — | $-4.7M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | $-1.6M | $-3.3M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | -3731.4% | ||
| Q2 25 | — | -1189.2% | ||
| Q1 25 | — | -1239.9% | ||
| Q4 24 | — | -561.5% | ||
| Q3 24 | -392.9% | -423.4% | ||
| Q2 24 | — | -1017.5% | ||
| Q1 24 | — | -566.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 41.6% | ||
| Q2 25 | — | 50.9% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | — | 2.2% | ||
| Q3 24 | 4.4% | 55.6% | ||
| Q2 24 | — | 41.9% | ||
| Q1 24 | — | 2.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
